CBI To Probe Ex-Assistant Drugs Controller Misconduct: High Court

New Delhi: In a significant development, the High Court of Punjab and Haryana has directed the Central Bureau of Investigation (CBI) to take over the investigation of a case involving alleged cheating by a former Assistant Drugs Controller of Himachal Pradesh, Nishant Sareen, among others.

The case came to light following allegations that the official, despite being directed by the Supreme Court to surrender to the trial court within four weeks, continued to attend office. This act of defiance raised questions about the support he might have received from the investigating agency handling the case.

The High Court’s decision was influenced by the petitioner’s counsel highlighting potential obstructions in the investigation, including the frequent reassignment of Investigating Officers, especially before court hearings. The court observed these actions as deliberate attempts to impede the judicial process.

Acknowledging the gravity of the accusations, which include complicity of police officers, the High Court deemed it necessary for an independent body like the CBI to conduct a fair and unbiased investigation.

“Taking into consideration the entire facts of the case and very serious allegations made against all the respondents including police officers, it is a fit case where the investigation has to be handed over to an independent agency like CBI for the purpose of fair and unbiased investigation,” the court noted in the order.

This order marks a pivotal move towards ensuring the integrity of the judicial system and upholding the rule of law. The CBI’s involvement is expected to bring transparency to the proceedings and address the serious allegations leveled against the respondents.

Related Posts

  • Pharma
  • July 26, 2024
  • 118 views
US FDA Finds Data Integrity, Sterility Problems At Brassica Pharma

Maryland: The US Food and Drug Administration (FDA) has warned Brassica Pharma for numerous good manufacturing practice (GMP) violations, including multiple instances of employees falsifying sterility and environmental monitoring data and…

  • Pharma
  • July 26, 2024
  • 108 views
Indian National Charged With Selling Counterfeit Cancer Drugs

HOUSTON: A federal grand jury has returned an indictment charging an Indian national with selling and shipping tens of thousands of dollars in counterfeit oncology pharmaceuticals into the United States,…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

US FDA Finds Data Integrity, Sterility Problems At Brassica Pharma

US FDA Finds Data Integrity, Sterility Problems At Brassica Pharma

Indian National Charged With Selling Counterfeit Cancer Drugs

Indian National Charged With Selling Counterfeit Cancer Drugs

ICMR Releases 32 New Treatment Standards For Treating Common And Serious Diseases

ICMR Releases 32 New Treatment Standards For Treating Common And Serious Diseases

BIS Sanctioned 82 Medical Device Projects To Develop Standards

BIS Sanctioned 82 Medical Device Projects To Develop Standards

Anti-Narcotics Task Force Will Be Formed Soon In Rajasthan: HM

Anti-Narcotics Task Force Will Be Formed Soon In Rajasthan: HM

‘Sunrise’ MedTech Industry in India & ‘Clouds’ strangling it, Brainstormed in PHD

‘Sunrise’ MedTech Industry in India & ‘Clouds’ strangling it, Brainstormed in PHD